There are 2789 resources available
1203P - The analysis of ALK fusion variants in 4991 EGFR/MET mutation-negative non-squamous non-small cell lung carcinomas (NSCLCs)
Presenter: Evgeny Imyanitov
Session: ePoster Display
1204P - Cost-benefit analysis of ALK diagnosis in patients with non-small cell lung cancer in Spain
Presenter: Ana Laura Ortega Granados
Session: ePoster Display
1205P - Treatment sequencing and duration of subsequent tyrosine kinase inhibitors in ALK+ non-small cell lung cancer patients treated with brigatinib in the US
Presenter: Mohammad Jahanzeb
Session: ePoster Display
1206P - UNcommon EGFR mutations: International Case series on efficacy of Osimertinib in Real-life practice in first-liNe setting (UNICORN)
Presenter: Jair Bar
Session: ePoster Display
1145P - Reliable detection of BRCA1 and BRCA2 large genomic rearrangements in FFPE tissue: A new diagnostic benchmark for somatic BRCA testing
Presenter: Nadejda Valtcheva
Session: ePoster Display
1146P - Closing the target gap: A computational approach to optimizing therapeutic selection for cancer patients
Presenter: Mikhail Grushko
Session: ePoster Display
1147P - AI-based detection of molecular biomarkers directly from H&E scanned slide
Presenter: Nir Peled
Session: ePoster Display
1148P - Identification and validation of RET fusions in lung adenocarcinoma through DNA and RNA sequencing
Presenter: Yuchen Han
Session: ePoster Display
1149P - An automated platform for rapid drug screening in patient-derived micro-organospheres
Presenter: Zhaohui Wang
Session: ePoster Display